Palacio RCR, Pascual MML, Benítez MAM, Pichardo AL, Camacho SH, Solórzano SF, Vázquez RJG

Language: Spanish
References: 13
Page: 17-23
PDF size: 237.36 Kb.

ABSTRACT

In order to eradicate a disease globally, vaccination is the best way to prevent the transmission of infectious diseases. In Mexico, the National Survey 2012 showed a poor coverage with some vaccines in particular, but in the complete schemes, some age groups did not reach 50 percent.
Objective. To know the compliance vaccination by age group and noncompliance causes in children under 17 years old attend at a pediatric hospital.
Methods. Descriptive cross-sectional study. There were included children under 17 years old and companions who had their National Vaccination Card who were attended as outpatients from August to October 2015.
Results. 238 interviews were conducted, the average age of the children was 48 months (1-194), 50.4% were male, and 35% of the patients came from Mexico City. Most of patients were attended at Nephrology, Cardiology and Gastroenterology (42%) services. Compliance of complete schemes was 35.5%, being higher in children under one year (41.5%) and lower in those over 12 years old (23%). Compliance by vaccine was BCG 97%, HBV 83%, pentavalent 85%, rotavirus 63%, pneumococcus 76%, and MMR 73%. The main reasons for the non-compliance of the schemes were hospitalization, medical indication for no-vaccination, and lack of supply at the vaccination center. In adolescents, the HPV vaccine had a compliance of 66% in the first two doses and only 33% in the third.
Conclusion. In a third-level unit, compliance of vaccination schedules is low. A closer work is required between treating physicians and preventive medicine service.

REFERENCES

1. Hurtado Ochoterena, C.A. y Matías Juan, N.A., “Historia de la vacunación en México”, Rev Mex Puericultura Ped, 2005, 13: 47-52.

2. Fernández de Castro, J., “Simposio Bicentenario de la vacunación antivariolosa. Parte iii. La erradicación de la viruela en México”, Gac Med Méx, 1997, 133: 99-106.

3. Santos, J.L., Pérez, L.F. y Nakamura, M.A., “Inmunizaciones, vacunas y políticas de vacunación en México”, pac infecto-2, 2002, 6 (11): 574-622.

4. Gutiérrez, A. y Valdespino, J.L., Vacunas: ciencia y salud, México, Secretaría de Salud, 1992.

5. Consejo Nacional de Vacunación, Manual de procedimientos técnicos de vacunación. Programa de vacunación universal, México, Secretaría de Salud, actualización 2004.

6. García Velasco, L., Ortiz García, F., Carpio Ríos, D. y Gómez, M., “Programa de vacunación universal y semanas nacionales de salud. Lineamientos generales”, México, Secretaría de Salud, 2015.

7. Santos, J.L., “El programa nacional de vacunación: orgullo de México”, Rev Fac Med unam, 2002, 45: 142-153.

8. Díaz Ortega, J.L., Ferreira, E., García, L., Trejo, B., Téllez Rojo, M.M., Gutiérrez, J.P. y Hernández Ávila, M. “Niños”, en Gutiérrez J.P., Rivera-Dommarco, J. et al., Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales, Cuernavaca, Instituto Nacional de Salud Pública, 2012, pp. 55-64.

9. Díaz-Ortega, J.L., Ferreira-Guerrero, E. y Trejo-Valdivia, B., “Cobertura de vacunación en niños y adolescentes en México: esquema completo, incompleto y no vacunación”, Salud Pub Mex, 2013, 55 (supl 2): S289-S299.

10. Censia, Encuesta de cobertura de vacunación 2004- 2010, México, Secretaría de Salud.

11. Ljungman, P., “Vaccination of immunocompromised patients”, Clin Microbiol Infect, 2012, 18 (Suppl 5): 93-99.

12. Hung, T.Y., Kotecha, R.S., Blyth, C.C., Steed, S.K., Thornton, R.B., Ryan, A.L., Cole, C.H. y Richmond, P.C., “Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients”, Cancer, 2017, 123: 4215-4223.

13. Hofstetter, A.M., Camargo, S., Natarajan, K., Rosenthal, S.L. y Stockwell, M.S., “Vaccination. Coverage of adolescents with chronic medical conditions”, Am J Prev Med, 2017, 53: 680-688.